We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M Turnover 20%
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+41.71%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$336M
AUM Growth
+$172M
Cap. Flow
+$87.6M
Cap. Flow %
26.08%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
–
Avg Time Held
2.3 years
Top 10 Avg Time Held
2.3 years
Top 20 Avg Time Held
2.3 years

Top Buys

Rank Stock Value
1
RPTX icon
Repare Therapeutics
RPTX
+$96.4M

Top Sells

Rank Stock Value
1
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$8.77M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RPTX icon
1
DELISTED
Repare Therapeutics
RPTX
$93.2M 27.72%
+3,003,772
New +$96.4M
2020 Q2
0 quarters
HARP
2
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$75.1M 22.35%
452,443
– –
2019 Q1
5 quarters
TCRR
3
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$62.2M 18.51%
4,050,865
– –
2019 Q1
5 quarters
RYTM icon
4
Rhythm Pharmaceuticals
RYTM
$5.97B
$42.6M 12.67%
1,909,258
-450,205
-19% -$8.77M
2017 Q4
10 quarters
SNDX icon
5
Syndax Pharmaceuticals
SNDX
$1.21B
$32.1M 9.56%
2,168,691
– –
2016 Q1
17 quarters
CHMA
6
DELISTED
Chiasma, Inc. Common Stock
CHMA
$30.9M 9.18%
5,736,296
– –
2015 Q3
19 quarters

Similar funds

MPM Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, MPM Asset Management held 6 positions worth $336M, up 104% from $164M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management deployed $87.6M of net new capital in Q2 2020, opening 1 new position. Its largest new stake was Repare Therapeutics: 3,003,772 shares worth $93.2M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $8.77M trimmed.

  • MPM Asset Management's largest Q2 2020 buy was Repare Therapeutics: 3,003,772 shares worth $93.2M.
  • MPM Asset Management's biggest Q2 2020 reduction was Rhythm Pharmaceuticals, cutting an estimated $8.77M.
  • MPM Asset Management's ten largest holdings make up 100% of its $336M portfolio in Q2 2020.
  • MPM Asset Management opened 1 new position and closed 0 in Q2 2020.
  • MPM Asset Management's portfolio value rose 104% quarter-over-quarter to $336M.

Based on MPM Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.